|
Real-time Estimate
Tradegate
10:52:56 2026-08-31 EDT
|
5-day change | 1st Jan Change | ||
| 4.508 EUR | -1.14% |
|
0.00% | -12.60% |
| 08-24 | Faes Farma: Mixed Q2; on track to meet full-year goals |  |
| 08-20 | Cancer vaccines finally garner the spotlight | |
| Market Cap | 1.42B 1.65B 1.33B 1.22B 2.29B 158B 2.3B 15.8B 6.16B 79.52B 6.19B 6.05B 264B | P/E 2026 * |
16.3x | P/E 2027 * | 12.9x |
|---|---|---|---|---|---|
| Enterprise Value | 1.7B 1.98B 1.6B 1.46B 2.75B 189B 2.76B 18.96B 7.4B 95.43B 7.43B 7.26B 316B | EV / Sales 2026 * |
2.32x | EV / Sales 2027 * | 2.1x |
| Free-Float |
78.08% | Yield 2026 * |
2.92% | Yield 2027 * | 3.62% |
Last Transcript : Faes Farma, S.A.
| 1 day | -1.14% | ||
| Current month | -1.10% | ||
| 1 month | -1.10% | ||
| 3 months | -1.10% | ||
| 6 months | -5.55% | ||
| Current year | -12.60% |
| 1 week | 4.5 |  | 4.6 |
| 1 month | 4.46 | | 4.6 |
| Current year | 4.32 | | 5.44 |
| 1 year | 4.1 | | 5.44 |
| 3 years | 2.86 | | 5.44 |
| 5 years | 2.86 | | 5.44 |
| 10 years | 2.57 | | 5.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2024-08-31 | |
| Director of Finance/CFO | - | 2025-07-13 | |
Isabel Nájera
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 1991-05-15 | |
| Director/Board Member | - | 2010-08-01 | |
| Director/Board Member | - | 2019-06-18 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/4/26 | Others | Director | 53,900 | 0.0170% | ||
| 2/4/26 | Others | Director | 87,383 | 0.0276% | ||
| 2/4/26 | Sell | Director | 24,000 | 0.0076% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.14% | 0.00% | +7.77% | +39.63% | 1.65B | |
| -1.78% | -7.53% | +56.84% | +108.06% | 1,047B | |
| -0.65% | -2.39% | +49.68% | +64.84% | 646B | |
| -0.02% | -3.35% | +20.64% | +73.97% | 451B | |
| -1.66% | -4.83% | +35.47% | +35.42% | 355B | |
| -0.53% | -2.93% | +21.17% | +37.77% | 291B | |
| -1.19% | -2.21% | +1.53% | +11.51% | 252B | |
| -0.45% | -3.06% | +49.96% | +67.85% | 234B | |
| -1.40% | -2.52% | -20.10% | -54.21% | 203B | |
| -0.12% | -1.15% | +28.69% | +89.66% | 181B | |
| Average | -0.86% | -2.42% | +25.17% | +47.45% | 366.09B | |
| Weighted average by Cap. | -0.96% | -3.46% | +36.29% | +64.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 733M 851M 687M 628M 1.18B 81.33B 1.19B 8.16B 3.18B 41.05B 3.19B 3.13B 136B | 793M 920M 744M 679M 1.28B 87.95B 1.28B 8.82B 3.44B 44.4B 3.46B 3.38B 147B |
| Net income | 87.37M 101M 81.91M 74.78M 141M 9.69B 141M 972M 379M 4.89B 381M 372M 16.22B | 111M 129M 104M 95M 179M 12.31B 180M 1.23B 482M 6.21B 484M 473M 20.61B |
| Net Debt | 284M 330M 267M 243M 458M 31.53B 460M 3.16B 1.23B 15.91B 1.24B 1.21B 52.77B | 248M 288M 233M 212M 400M 27.53B 402M 2.76B 1.08B 13.9B 1.08B 1.06B 46.09B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-31 | €4.510 | -1.10% | 52,158 |
| 26-08-28 | €4.560 | -0.22% | 44,733 |
| 26-08-27 | €4.570 | +0.55% | 83,593 |
| 26-08-26 | €4.545 | -0.22% | 77,327 |
| 26-08-25 | €4.555 | +1.00% | 61,430 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FAE Stock
Select your edition
All financial news and data tailored to specific country editions
